Physician profile
Richard Lee
NPI 1134238728
$19,114.11
in general payments reported to CMS, 2019-2025
16 companies · $764 in 2025
The $764 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2020: $8,526 · 2021: $8,179 · 2022: $363 · 2023: $503 · 2024: $622 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,889.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,888.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $16,509.76 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Medtronic, INC. | $871.68 | 2021-2025 | Penditure, Corevalve Evolut R, Micra |
| Abiomed | $544.57 | 2020-2024 | Impella |
| Edwards Lifesciences Corporation | $484.69 | 2019-2025 | Pascal, Mitris Resilia Mitral Valve, Edwards Mc3 Tricuspid Annuloplasty Ring |
| Medtronic Vascular, INC. | $427.22 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.79 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.73 | 2019 | |
| Abbott Laboratories | $33.30 | 2023-2025 | Mitraclip, Triclip |
| Getinge USA Sales, LLC | $31.64 | 2024 | Vasoview Hemopro 2 |
| Boston Scientific Corporation | $23.38 | 2019 | |
| Genzyme Corporation | $22.89 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.50 | 2023 | |
| Smith+Nephew, INC. | $17.80 | 2025 | Pico |
| Artivion, INC. | $15.18 | 2021 | |
| Bard Peripheral Vascular, INC. | $14.98 | 2023 | Venovo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.